Skip to main content
Caplight Logo









VedaBio

VedaBio

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.vedabio.com/

Last Round

Series A

Extension

Sep 23, 2025

Total Funding Raised

$40.13M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

VedaBio is a biotechnology company that develops molecular diagnostics equipment using a CRISPR-based platform for rapid, amplification-free detection of multiple analytes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

molecular diagnosticsCRISPR diagnosticspoint-of-care testingPOCTdecentralized diagnosticspathogen detectionbiotech platformdiagnostic hardwaremultiplexed assayslab-on-a-chiprapid testingdiagnostic consumablesclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VedaBio Comparables

Compare VedaBio with similar companies based on industry and business-model similarity.

VedaBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IntelliGenome
83%
GRIP Molecular Technologies
79%
OraSure Technologies Inc
78%

VedaBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 23, 2025
Series AOct 17, 2023

Key People

Founding team and executive leadership

Frederic D. Sweeney

Board Director, President And Chief Executive Officer

Executive Team

Maurice Exner

Chief Operating Officer

Executive Team

VedaBio Investors

Notable investors and investment history

VedaBio investors
InvestorRounds
OMX VenturesSeries A, Series A Extension
Kleinmuntz AssociatesSeries A, Series A Extension
Y CombinatorAccelerator
OMX VenturesSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2025

    $40M round completed.

  • Sep 23, 2025

    Signed a strategic agreement with Siemens Healthineers.

VedaBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VedaBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VedaBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range25
Year Founded2021
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?